Posted in

I. GENERAL PHARMACOLOGY – Self learning series -1 with Dr sheen Page # 1 unit -1, Edition 2023 south Asian

GENERAL PHARMACOLOGY - Self learning series -1 with Dr sheen Page # 1 unit -1, Edition 2023 south Asian
Signature: 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
  • The word pharmacology comes from:
    • Pharmacon = an active principle or drug.
    • Logus = discourse or study.
  • Pharmacology is the science that studies substances that interact with living systems through chemical processes.
  • These substances work mainly by binding to regulatory molecules.
  • They can activate or inhibit normal body functions.
  • These substances are usually given as drugs to produce beneficial therapeutic effects in patients.
  • Pharmacology is a branch of medicine that combines several biomedical sciences, including:
    • Chemistry
    • Biochemistry
    • Physiology
    • Clinical medicine
  • Pharmacology is both:
    • A basic science.
    • An applied science.
  • Pharmacology is the foundation of rational drug therapy.
  • Pharmacology studies:
    • Sources of drugs.
    • Biochemical effects of drugs.
    • Physiological effects of drugs.
    • Mechanism of action of drugs.
    • Therapeutic uses of drugs.
    • Adverse effects of drugs.
  • Pharmacology also explains:
    • What effects drugs produce.
    • How drugs produce those effects.
  • Example: Paracetamol
    • Lowers body temperature during fever.
    • It works by inhibiting the enzyme cyclooxygenase (COX) in the CNS.
    • This reduces the production of inflammatory mediators.
  • Example: Penicillin
    • Treats certain bacterial infections.
    • It inhibits a key enzyme needed for bacterial cell wall synthesis.
    • As a result, bacterial cell walls cannot form properly.
  • In 1966, the World Health Organization (WHO) defined a drug as:
    • Any substance or product used or intended to modify or study physiological systems or pathological conditions for the benefit of the patient.
  • According to the New Drugs and Clinical Trials Rules, 2018 (India):
    • An Active Pharmaceutical Ingredient (API) is any substance used in a pharmaceutical formulation.
    • It provides pharmacological activity.
    • It may also directly help in:
      • Diagnosis
      • Cure
      • Mitigation
      • Treatment
      • Prevention of disease
      • Restoring normal physiological functions
      • Correcting physiological functions
      • Modifying physiological functions
    • It can be used in both humans and animals.
  • Drugs are chemical substances that affect living organisms.
  • Clinicians use drugs to:
    • Diagnose diseases.
    • Prevent diseases.
    • Treat diseases.
  • Safe use of drugs requires knowledge of:
    • Mechanism of action.
    • Drug doses.
    • Routes of administration.
    • Adverse drug effects.
    • Drug interactions.
  • Medicinal or organic chemists create a new candidate molecule called a New Chemical Entity (NCE).
  • Pharmacologists test the NCE:
    • In vitro.
    • On isolated tissues.
    • In cell cultures.
    • In animals (in vivo).
    • In humans.
  • Successful testing can lead to the discovery of new therapeutic drugs.
  • General pharmacology includes the study of:
    • Sources of drugs.
    • Routes of drug administration.
    • Drug absorption.
    • Factors affecting absorption.
    • Drug distribution.
    • Drug biotransformation (metabolism).
    • Drug excretion.
    • Drug–receptor interaction.
    • Mechanism of drug action.
    • Adverse drug effects.
    • Preclinical evaluation.
    • Clinical evaluation.

KEY CONCEPT

  • Pharmacology is the science of drugs and their effects on living systems.
  • It combines chemistry, biochemistry, physiology, and clinical medicine.
  • It explains drug sources, actions, uses, adverse effects, and mechanisms.
  • Drugs act by interacting with regulatory molecules to activate or inhibit body functions.
  • Safe drug therapy requires understanding drug action, dose, administration, adverse effects, and interactions.
  • New drugs are developed by creating New Chemical Entities (NCEs) and testing them from laboratory studies to human trials.
  • General pharmacology mainly covers drug sources, administration, absorption, distribution, metabolism, excretion, receptor interaction, adverse effects, and drug evaluation.

A. Branches of Pharmacology

  • Pharmacology has two main branches:
    1. Pharmacokinetics
    2. Pharmacodynamics

1. Pharmacokinetics (What the body does to the drug)

  • Pharmacokinetics studies what happens to a drug inside the body.
  • It describes the movement of the drug through the body.
  • It includes:
    • Absorption
    • Distribution
    • Biotransformation (metabolism)
    • Excretion
  • Example: Chlorpromazine
    • It is absorbed faster by the parenteral route than by the oral route.
    • It binds to plasma proteins and tissue proteins.
    • It is metabolized in the liver.
    • It is excreted within 15–30 hours.

2. Pharmacodynamics (What the drug does to the body)

  • Pharmacodynamics studies how a drug acts on the body.
  • It explains the:
    • Molecular actions of the drug.
    • Biological actions of the drug.
    • Therapeutic actions of the drug.
  • Example: Pantoprazole
    • It inhibits the proton pump (H⁺/K⁺ ATPase).
    • This decreases acid secretion in the stomach.
  • The relationship between pharmacokinetics and pharmacodynamics is shown in Figure 1.1.

KEY CONCEPT

  • Pharmacology has two major branches:
    • Pharmacokinetics = What the body does to the drug (Absorption, Distribution, Biotransformation, Excretion).
    • Pharmacodynamics = What the drug does to the body (Drug action and therapeutic effects).
  • Chlorpromazine is an example of pharmacokinetics.
  • Pantoprazole is an example of pharmacodynamics.
  • Figure referenced: Figure 1.1.

B. Other Branches

1. Pharmacotherapeutics

  • Pharmacotherapeutics is the branch of medicine that applies pharmacokinetic and pharmacodynamic principles in clinical practice.
  • It is used for:
    • Treatment of disease.
    • Diagnosis of disease.
    • Prevention of disease.

2. Toxicology

  • Toxicology is the science of poisons.
  • Poisons are substances that are harmful, dangerous, or can cause death in humans and animals.
  • Many drugs can act as poisons when given in large doses.
  • Example: Aspirin
    • In low doses, it acts as an anticoagulant.
    • It works by inhibiting thromboxane A₂.
    • It is useful for heart patients.
    • In high doses, it can cause gastric ulceration.
    • Severe bleeding may occur and can be fatal.

3. Chemotherapy

  • Chemotherapy studies the effects of drugs on microorganisms and parasites living inside the body.
  • It is also used to treat cancer by targeting cancer cells.

4. Clinical Pharmacology

  • Clinical pharmacology studies drugs and their clinical use.
  • It provides information about:
    • Drug potency.
    • Drug usefulness.
    • Drug doses.
    • Drug toxicity.
  • It helps ensure the safe clinical use of drugs.
  • It includes:
    • Clinical trials of new drugs in humans.
    • Identification of adverse drug reactions.
    • Reporting of adverse drug reactions.
    • Rational use of drugs.
    • Essential drug concept.

5. Pharmacoepidemiology

  • Pharmacoepidemiology studies the effects of drugs on populations.

6. Pharmacoeconomics

  • Pharmacoeconomics studies:
    • Cost-effectiveness of drug treatment.
    • Cost of medications.
  • It is especially important for groups such as:
    • Elderly patients.
    • AIDS patients.

7. Pharmacogenetics

  • Pharmacogenetics studies genetic variations that cause different drug responses among individuals and populations.
  • Some people show greater-than-normal sensitivity to standard drug doses.
  • Genetic screening before prescribing may help provide individualized therapy.

8. Pharmacogenomics

  • Pharmacogenomics applies genomic technologies to:
    • Discover new drugs.
    • Further study and improve older drugs.

9. Pharmacognosy

  • Pharmacognosy studies drugs obtained from:
    • Plants.
    • Animals.

10. Pharmacy

  • Pharmacy is the art and science of preparing suitable dosage forms for drug administration in humans and animals.
  • It also involves:
    • Dispensing drugs.
    • Identification of medicinal substances.
    • Selection of medicinal substances.
    • Collection of medicinal substances.
    • Purification of medicinal substances.
    • Isolation of medicinal substances.
    • Standardization of medicinal substances.
    • Quality control of medicinal substances.

11. Clinical Pharmacy

  • Clinical pharmacy is a health science in which pharmacists provide patient care to optimize drug therapy.
  • It promotes:
    • Health.
    • Wellness.
    • Disease prevention.
  • It is patient-oriented.
  • It includes advising patients on the proper use of:
    • Prescribed drugs.
    • Over-the-counter (OTC) drugs.

12. Pharmacovigilance

  • Pharmacovigilance involves:
    • Monitoring adverse drug events.
    • Detecting adverse drug events.
    • Reporting adverse drug events.
    • Taking remedial measures.

KEY CONCEPT

  • Pharmacotherapeutics: Clinical use of drugs for treatment, diagnosis, and prevention.
  • Toxicology: Study of poisons and toxic effects of drugs.
  • Chemotherapy: Drugs used against microorganisms, parasites, and cancer cells.
  • Clinical Pharmacology: Safe clinical use of drugs, including clinical trials and adverse drug reaction monitoring.
  • Pharmacoepidemiology: Study of drug effects in populations.
  • Pharmacoeconomics: Study of the cost-effectiveness of drug therapy.
  • Pharmacogenetics: Study of genetic differences affecting drug response.
  • Pharmacogenomics: Use of genomic technology in drug discovery and development.
  • Pharmacognosy: Study of drugs from plant and animal sources.
  • Pharmacy: Preparation, dispensing, and quality control of medicines.
  • Clinical Pharmacy: Patient-centered pharmacy care and medication counseling.
  • Pharmacovigilance: Monitoring, detecting, reporting, and preventing adverse drug events.

C. Definitions

1. Pharmacopoeia

  • Pharmacopoeia is an official reference book.
  • It contains a selected list of established drugs and medicinal preparations.
  • It describes:
    • Physical properties of drugs.
    • Tests for drug identity.
    • Drug purity.
    • Drug potency.
  • It sets the official standards for drug preparations.
  • Some well-known pharmacopoeias are:
    • British Pharmacopoeia (BP)
    • Indian Pharmacopoeia (IP)
    • International Pharmacopoeia (IP)
    • United States Pharmacopoeia (USP)
  • The description of a drug preparation in a pharmacopoeia is called a monograph.
  • A monograph includes:
    • Drug description.
    • Identification characteristics.
    • Standards of purity.
    • Standards of strength.
    • Limits of impurities.
    • Drug assay method.
    • Storage instructions.
    • Other instructions.

2. National Formulary

  • A National Formulary is a collection of drugs recognized as legal standards.
  • It specifies the standards of:
    • Purity.
    • Quality.
    • Strength.
  • It is published by the government or authorized health agency of a country.
  • Examples:
    • National Formulary of India — published by the Government of India.
    • British National Formulary (BNF) — jointly published by the British Medical Association (BMA) and the Royal Pharmaceutical Society.

3. Essential Medicines

  • According to the WHO, Essential Medicines are those that meet the priority healthcare needs of the population.
  • These medicines should be:
    • Available at all times.
    • Available in adequate amounts.
    • Supplied in appropriate dosage forms.
    • Of assured quality.
    • Provided with adequate information.
    • Affordable for individuals and the community.
    • Available within a functioning healthcare system.

4. Orphan Drugs

  • Orphan drugs are:
    • Drugs.
    • Vaccines.
    • Biological products.
  • They are used for:
    • Diagnosis.
    • Prevention.
    • Treatment of rare diseases.
    • Treatment of some common diseases that are mainly found in poor countries.
  • Pharmaceutical companies have little interest in developing these drugs because they provide very little commercial profit.
  • Developing orphan drugs requires:
    • Very high development costs.
    • Low expected sales.
  • Therefore, the development cost is often not recovered.
  • In India, an orphan drug is intended to treat a disease affecting not more than 5 lakh people.
  • Clinical studies in children are highly restricted because of ethical and legal reasons.
  • Many rare diseases occur in children.
  • Diseases affecting very small patient populations are called orphan diseases because only a few approved treatment options are available.
  • Rare (or orphan) diseases affect about 6–8% of the world’s population.
  • Examples of orphan diseases:
    • Infantile spinal muscular atrophy.
    • Cystic fibrosis.
    • Patent ductus arteriosus (PDA).
    • Lysosomal storage disorders.
    • Familial adenomatous polyposis (FAP).
    • Acute intermittent porphyria.
  • Examples of orphan drugs:
    • Miglustat — Type 1 Gaucher disease.
    • Iloprost — Pulmonary arterial hypertension in patients with NYHA Class III or IV symptoms.
    • Bosentan — WHO Class II–IV pulmonary arterial hypertension symptoms.
    • Pegvisomant — Acromegaly.
    • Busulfan — Allogeneic hematopoietic progenitor cell transplantation for chronic myelogenous leukemia.
  • Many countries have made laws to encourage orphan drug development.
  • These countries provide incentives and support for developing orphan drugs.

KEY CONCEPT

  • Pharmacopoeia: Official book that sets standards for drugs and medicinal preparations through monographs.
  • National Formulary: Government-approved reference that defines the legal standards of drug purity, quality, and strength.
  • Essential Medicines: WHO-listed medicines that should always be available, affordable, effective, and of assured quality.
  • Orphan Drugs: Drugs developed for rare diseases or diseases with little commercial interest.
  • Orphan Diseases: Rare diseases affecting small populations, often with limited treatment options.
  • Many governments encourage orphan drug development by providing legal and financial support.

D. Pharmacoeconomics

  • Pharmacoeconomics is the description and analysis of the costs of drug therapy for healthcare systems and society.
  • It helps use limited healthcare resources to provide the maximum benefit to:
    • Patients.
    • Healthcare payers.
    • Society.
  • Pharmacoeconomics is used to:
    • Develop healthcare guidelines.
    • Support healthcare policy decisions.
    • Plan national health policies.
  • Information from pharmacoeconomics is important for national healthcare spending.
  • It helps choose the best treatment options when resources are limited.
  • The main purpose of pharmacoeconomics is to:
    • Analyze healthcare costs.
    • Allocate resources appropriately.
    • Guide research and investment in specific drugs or drug groups.
    • Compare the cost of one drug or drug therapy with another.
  • Pharmacoeconomics is a subdivision of health economics.

Need of Pharmacoeconomics

  • Minimize healthcare expenditure while achieving the best healthcare outcomes.
  • Reduce the cost of drugs and healthcare-related services.
  • The relevant components are shown in Figure 1.2.
  • Pharmacoeconomics considers:
    • Direct costs.
    • Indirect costs.
    • Other healthcare expenses.
  • It evaluates healthcare from the perspective of:
    • Patients.
    • Healthcare providers.
    • Payers.
    • Society.
  • Both direct and indirect costs are included in pharmacoeconomic analysis.
  • Outcome analysis includes:
    • Clinical outcomes
      • Disease outcomes.
      • Treatment outcomes.
      • Morbidity.
      • Mortality.
    • Economic outcomes
      • Direct costs.
      • Indirect costs.
      • Tangible costs.
    • Humanistic outcomes
      • Patient preferences.
      • Quality of life.
  • Different pharmacoeconomic methods are shown in Figure 1.3.

KEY CONCEPT

  • Pharmacoeconomics studies the cost and value of drug therapy.
  • It helps use limited healthcare resources efficiently.
  • It supports healthcare guidelines, policy decisions, and national health planning.
  • It compares the costs of different drugs and treatment options.
  • It considers:
    • Direct costs.
    • Indirect costs.
    • Clinical outcomes (disease, treatment, morbidity, mortality).
    • Economic outcomes (direct, indirect, and tangible costs).
    • Humanistic outcomes (patient preference and quality of life).
  • Pharmacoeconomics is a subdivision of health economics.

E. Sources of Drugs (Figure 1.4)

  • Drugs are mainly obtained from:
    • Plants.
    • Animals.
    • Microorganisms.
    • Minerals.
  • Today, most therapeutic drugs are produced from:
    • Synthetic products.
    • Semisynthetic products.

1. Animal Sources

  • Drugs obtained from animals include:
    • Insulin.
    • Heparin.
    • Gonadotrophins.
    • Thyroid extract.
    • Antitoxic sera (e.g., antisnake venom).

2. Mineral Sources

  • Drugs obtained from minerals include:
    • Liquid paraffin.
    • Ferrous sulfate.
    • Magnesium sulfate.
    • Magnesium trisilicate.
    • Kaolin.

3. Microorganisms (Bacteria and Fungi)

  • Many important antibiotics are obtained from microorganisms, including:
    • Penicillin.
    • Streptomycin.
    • Erythromycin.
    • Polymyxin B.
    • Bacitracin.
    • Chloramphenicol.
    • Nystatin.
    • Griseofulvin.
  • Other useful products produced by microorganisms include:
    • Streptokinase
      • An enzyme produced by Streptococcus pyogenes (gram-positive cocci).
    • Vitamin B₁₂ (Cyanocobalamin)
      • Produced by Streptomyces griseus.

KEY CONCEPT

  • Drugs are obtained mainly from:
    • Plants.
    • Animals.
    • Microorganisms.
    • Minerals.
  • Most modern drugs are synthetic or semisynthetic.
  • Animal sources: Insulin, heparin, gonadotrophins, thyroid extract, antisnake venom.
  • Mineral sources: Liquid paraffin, ferrous sulfate, magnesium sulfate, magnesium trisilicate, kaolin.
  • Microorganisms: Produce many antibiotics and other products such as streptokinase and vitamin B₁₂.

E. Sources of Drugs (Figure 1.4)

  • Drugs are mainly obtained from:
    • Plants.
    • Animals.
    • Microorganisms.
    • Minerals.
  • Today, most therapeutic drugs are produced from:
    • Synthetic products.
    • Semisynthetic products.

1. Animal Sources

  • Drugs obtained from animals include:
    • Insulin.
    • Heparin.
    • Gonadotrophins.
    • Thyroid extract.
    • Antitoxic sera (e.g., antisnake venom).

2. Mineral Sources

  • Drugs obtained from minerals include:
    • Liquid paraffin.
    • Ferrous sulfate.
    • Magnesium sulfate.
    • Magnesium trisilicate.
    • Kaolin.

3. Microorganisms (Bacteria and Fungi)

  • Many important antibiotics are obtained from microorganisms, including:
    • Penicillin.
    • Streptomycin.
    • Erythromycin.
    • Polymyxin B.
    • Bacitracin.
    • Chloramphenicol.
    • Nystatin.
    • Griseofulvin.
  • Other useful products produced by microorganisms include:
    • Streptokinase
      • An enzyme produced by Streptococcus pyogenes (gram-positive cocci).
    • Vitamin B₁₂ (Cyanocobalamin)
      • Produced by Streptomyces griseus.

KEY CONCEPT

  • Drugs are obtained mainly from:
    • Plants.
    • Animals.
    • Microorganisms.
    • Minerals.
  • Most modern drugs are synthetic or semisynthetic.
  • Animal sources: Insulin, heparin, gonadotrophins, thyroid extract, antisnake venom.
  • Mineral sources: Liquid paraffin, ferrous sulfate, magnesium sulfate, magnesium trisilicate, kaolin.
  • Microorganisms: Produce many antibiotics and other products such as streptokinase and vitamin B₁₂.

E. Sources of Drugs (Figure 1.4)

  • Gum Resins
    • Asafetida
      • Used as a carminative.
      • Used as an antispasmodic.
  • Oleo Gum Resin
    • Myrrh
      • Has local stimulant properties.
      • Has antiseptic properties.
      • Commonly used in mouthwash.
  • Balsams
    • Benzoin
      • Used internally as an expectorant.
      • Used externally as an astringent.
    • Balsam Tolu
      • Used as a stimulating expectorant.
  • Gums
    • Gums are secretory products of plants.
    • On hydrolysis, they produce simple sugar-like polysaccharides.
    • They are pharmacologically inert.
    • They are mainly used as:
      • Suspending agents.
      • Emulsifying agents.
    • Common examples:
      • Gum acacia.
      • Tragacanth.
  • Tannins
    • Tannins are non-nitrogenous plant constituents.
    • Chemically, they are phenolic derivatives.
    • They are known for their astringent action.
    • They are commonly used in the treatment of:
      • Diarrhea.
      • Burns.
    • Important plant sources include:
      • Hirda (used in combination as Triphala).
      • Amla.
      • Behera.
      • Ashoka bark.
      • Black catechu.

KEY CONCEPT

  • Asafetida (Gum resin): Carminative and antispasmodic.
  • Myrrh (Oleo gum resin): Local stimulant, antiseptic, and used in mouthwash.
  • Benzoin (Balsam): Expectorant internally and astringent externally.
  • Balsam Tolu: Stimulating expectorant.
  • Gums: Plant secretions that are pharmacologically inert and used as suspending and emulsifying agents.
  • Tannins: Phenolic plant compounds with astringent action, used for diarrhea and burns.

Note: This text is part of Figure 1.4 (Sources of Drugs). MADE BY SELF LEARNING DR SHEEN

Leave a Reply

Your email address will not be published. Required fields are marked *